| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/0049-3848(88)90029-1 |
| P698 | PubMed publication ID | 3146823 |
| P2093 | author name string | Rossi E | |
| Lombardi A | |||
| Mondonico P | |||
| Preda L | |||
| P433 | issue | 5 | |
| P304 | page(s) | 453-468 | |
| P577 | publication date | 1988-12-01 | |
| P1433 | published in | Thrombosis Research | Q15758741 |
| P1476 | title | Method for the determination of functional (clottable) fibrinogen by the new family of ACL coagulometers | |
| P478 | volume | 52 |
| Q42236749 | A fast and simple approach to the quantitative evaluation of fibrinogen coagulation |
| Q30429127 | A novel μ-fluidic whole blood coagulation assay based on Rayleigh surface-acoustic waves as a point-of-care method to detect anticoagulants |
| Q73154033 | Abnormalities of coagulation in hypertensive patients with reduced creatinine clearance |
| Q44847409 | Automation of prothrombin time on the Cobas Fara II centrifugal analyser |
| Q45871584 | Clot waveform analysis: Where do we stand in 2017? |
| Q33884236 | Co-ordinated spatial propagation of blood plasma clotting and fibrinolytic fronts |
| Q45864184 | Comparison of the fibrinogen Clauss assay and the fibrinogen PT derived method in patients with dysfibrinogenemia |
| Q35587305 | Determination of plasma fibrinogen concentrations in beagle dogs, cynomolgus monkeys, New Zealand white rabbits, and Sprague-Dawley rats by using Clauss and prothrombin-time-derived assays. |
| Q50967844 | Direct comparisons of three alternative plasma fibrinogen assays with the von Clauss assay in prediction of cardiovascular disease and all-causes mortality: the Scottish Heart Health Extended Cohort. |
| Q37872566 | Discriminative value of serum amyloid A and other acute-phase proteins for coronary heart disease |
| Q32052986 | Do HMG-CoA reductase inhibitors affect fibrinogen? |
| Q77643955 | Elevated serum lipoprotein(a) is a risk factor for left atrial thrombus in patients with chronic atrial fibrillation: a transesophageal echocardiographic study |
| Q49170028 | Haptoglobin polymorphism and peripheral arterial occlusive disease |
| Q86657869 | Influence of anti-VEGF about cardiovascular biomarkers in age related macular degeneration |
| Q35576140 | Level of fibrinogen and risk of fatal and non-fatal stroke. EUROSTROKE: a collaborative study among research centres in Europe |
| Q37872569 | Parameters of inflammation and infection in a community based case-control study of coronary heart disease |
| Q28544736 | Pathogen reduction in human plasma using an ultrashort pulsed laser |
| Q51596762 | Plasma fibrinogen in relation to serum insulin, smoking habits and adipose tissue fatty acids in healthy men. |
| Q51063246 | Platelet recruitment to venous stent thrombi. |
| Q37359607 | Pregnancy in congenital afibrinogenaemia: report of a successful case and review of the literature |
| Q39596925 | Prothrombin time derived fibrinogen determination on Sysmex CA-6000. |
| Q32056571 | Relationship of lipoprotein(a) to variables of coagulation in hypertensive subjects |
| Q45201529 | Risk factors for cardiac autonomic neuropathy in type 1 diabetes mellitus |
| Q54174971 | Selective removal of plasma low density lipoprotein with the HELP system: biweekly versus weekly therapy |
| Q95432986 | Statins and fibrinogen |
| Q30671044 | The EUROSTROKE cohorts: a short description and data analytical approach |
| Q38894614 | The amplitude of coagulation curves from thrombin time tests allows dysfibrinogenemia caused by the common mutation FGG-Arg301 to be distinguished from hypofibrinogenemia. |
| Q67843242 | The suitability of the australasian reference thromboplastin for use on an automated centrifugal analyser |
| Q74035322 | Weight change and blood coagulability and fibrinolysis in healthy obese women |
Search more.